Beauty Health CFO RSU tax withholding on 58,573 shares

Beauty Health Co Chief Financial Officer Michael P. Monahan reported a tax-related share disposition tied to vesting of restricted stock units.

Rhea-AI Filing Summary

Beauty Health Co Chief Financial Officer Michael P. Monahan reported a tax-related share disposition tied to vesting of restricted stock units. The filing shows 58,573 shares of Class A Common Stock valued at $1.17 per share were withheld by the company to satisfy tax withholding requirements and explicitly notes this does not represent a sale in the market. After this withholding, Monahan directly holds 1,267,732 shares of Class A Common Stock, indicating he retains a substantial equity position following the RSU vesting event.

Insider Trade Summary

Exercise Price or Tax Liability: 58,573 shares

Exercise Price or Tax Liability 1 txn

Insider MONAHAN MICHAEL P.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A Common Stock	58,573	$1.17	$69K

Holdings After Transaction: Class A Common Stock — 1,267,732 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Beauty Health (SKIN) CFO Michael Monahan report in this Form 4?

Beauty Health CFO Michael P. Monahan reported a tax-related share disposition. The company withheld 58,573 Class A Common Stock shares at $1.17 per share to cover tax withholding on RSU vesting, while he retained 1,267,732 shares afterward.

Did the Beauty Health (SKIN) CFO sell shares in the open market?

No, the filing states the shares did not represent a sale. The 58,573 shares were withheld by Beauty Health to satisfy tax withholding requirements on restricted stock unit vesting, a common non-market transaction for equity compensation.

How many Beauty Health (SKIN) shares were withheld for the CFO’s tax obligations?

The Form 4 shows 58,573 shares of Beauty Health Class A Common Stock were withheld. The price used was $1.17 per share, and the footnote clarifies this was solely to satisfy tax withholding requirements related to RSU vesting.

What is the Beauty Health (SKIN) CFO’s shareholding after this Form 4 transaction?

After the tax-withholding transaction, CFO Michael P. Monahan directly owns 1,267,732 shares. This figure reflects his Class A Common Stock holdings following the 58,573-share withholding associated with restricted stock unit vesting.

What does transaction code F mean in the Beauty Health (SKIN) Form 4?

Transaction code F indicates payment of an exercise price or tax liability by delivering securities. In this case, 58,573 shares were withheld by Beauty Health to cover tax withholding on RSU vesting, rather than sold in the open market.

Is the Form 4 transaction for Beauty Health (SKIN) CFO considered a tax-withholding disposition?

Yes, the transaction is classified as a tax-withholding disposition. The company withheld 58,573 shares to meet tax obligations from restricted stock unit vesting, and the footnote confirms it does not represent an actual sale of shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MONAHAN MICHAEL P.

(Last) (First) (Middle)

C/O THE BEAUTY HEALTH COMPANY

3600 E. BURNETT STREET

(Street)

LONG BEACH CALIFORNIA 90815

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/17/2026		F(1)		58,573	D	$1.17	1,267,732	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

Remarks:

	/s/ Paul Bokota, Attorney-in-fact for Michael Monahan	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)